Atlas Trials

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Clinical trial NCT00257205 · COMPLETED

Trial details

NCT number
NCT00257205
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Melanoma
Start date
2006-03-01
Primary completion
2010-08-01
Enrollment
655

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.